Stay updated on Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.

Latest updates to the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label changed from v3.6.4 to v3.6.5. This reflects a backend or formatting update to the page, while the study content remains unchanged.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe site version was updated from v3.6.3 to v3.6.4, representing an incremental platform update that does not alter the study information or text on the page.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a minor page update or maintenance revision without changes to the visible content or user functionality.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0, reflecting a small site update to the study record display.SummaryDifference0.1%

- Check67 days agoChange DetectedRecruitment status now indicates no longer looking for participants. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the footer revision updated to v3.6.0 with a formatting tweak to the Intervention/Treatment heading.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a small backend/template update rather than a change to the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.